Hongyan Liu

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Glycemic Control

Structural Basis

Cardiovascular Disease

Top Venues

Diabetes, obesity & metabolism

Current diabetes reports

This page only lists publications with an associated author ORCID identifier.

Publications

Hongyan Liu, Vikas S Sridhar, Bruce A Perkins, Julio Rosenstock, David Z I Cherney
SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis. Current diabetes reports 22 (7) (2022)
Patrick R Lawler, Hongyan Liu, Claudia Frankfurter, Leif Erik Lovblom, Yuliya Lytvyn, Dylan Burger, Kevin D Burns, Davor Brinc, David Z I Cherney
Changes in Cardiovascular Biomarkers Associated With the Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes. Diabetes care 44 (3) (2021)
Hongyan Liu, Vikas S Sridhar, Daniel Montemayor, Leif Erik Lovblom, Yuliya Lytvyn, Hongping Ye, Jiwan Kim, Mir Tariq Ali, Daniel Scarr, Patrick R Lawler, Bruce A Perkins, Kumar Sharma, David Z I Cherney
Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes. Diabetes, obesity & metabolism 23 (11) (2021)